← All Investors
CITIUS PHARMACEUTICALS INC
CTXR
Holders
1
Combined Value
$26K
Combined Shares
29,100
Current Price
$0.54
52W High
$2.48
vs 52W High
−78.2%
Investor Activity
BUYSELLImplied priceClick a quarter to see who traded
Held By
| Investor | Value | % of Portfolio | Avg Buy Price | Gain | Last Activity | As of |
|---|---|---|---|---|---|---|
| Ken Griffin - Citadel Advisors | $26K | 0.00% | ~$2.12 | −74.5% | Sold Q1 2026 | Q1 2026 |
Recent Activity
| Quarter | Investor | Action | Est. Value | Est. Price |
|---|---|---|---|---|
| Q1 2026 | Ken Griffin - Citadel Advisors | SELL | −$34K | ~$0.90 |
| Q4 2025 | Ken Griffin - Citadel Advisors | SELL | −$28K | ~$0.78 |
| Q3 2025 | Ken Griffin - Citadel Advisors | BUY | +$51K | ~$1.24 |
| Q2 2025 | Ken Griffin - Citadel Advisors | BUY | +$52K | ~$1.59 |
| Q1 2025 | Israel Englander - Millennium Management | SOLD OUT | −$129K | ~$4.00 |
| Q1 2025 | Ken Fisher - Fisher Investments | SOLD OUT | −$51K | ~$4.00 |
| Q1 2025 | Ken Griffin - Citadel Advisors | SELL | −$6K | ~$1.49 |
| Q4 2024 | Ken Griffin - Citadel Advisors | NEW BUY | +$130K | ~$4.00 |
| Q4 2024 | Israel Englander - Millennium Management | NEW BUY | +$129K | ~$4.00 |
| Q4 2024 | Ken Fisher - Fisher Investments | NEW BUY | +$51K | ~$4.00 |
Ownership History
| Period | Holders | Total Shares | Δ Shares | Total Value | Implied Price |
|---|---|---|---|---|---|
| Q1 2026 | 1 | 29,100 | −56.6% | $26K | $0.90 |
| Q4 2025 | 1 | 67,100 | −35.0% | $52K | $0.78 |
| Q3 2025 | 1 | 103,200 | +67.8% | $127K | $1.24 |
| Q2 2025 | 1 | 61,500 | +115.2% | $97K | $1.59 |
| Q1 2025 | 1 | 28,580 | −63.3% | $42K | $1.49 |
| Q4 2024 | 3 | 77,857 | — | $311K | $4.00 |